Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnny Yang

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cureus|November 12, 2024
Precision Population Cancer Medicine in Brain Tumors: A Potential Roadmap to Improve Outcomes and Strategize the Steps to Bring Interdisciplinary InterventionsUmesh Velu, Anshul Singh, Roselin Nittala, et al.
Cureus|March 24, 2026
High-Value Care Inclusion in the Preclinical and Clinical Years of Medical School: A Narrative Review and Descriptive Experience at a Single InstitutionLauren K Storm, John D Salvemini, Micaela L Shields, et al.
Molecular Cancer Therapeutics|December 23, 2011
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimensYuichi Hikichi, Kohei Honda, Kouki Hikami, et al.
Cureus|January 25, 2023
Changing Role of PET/CT in Cancer Care With a Focus on RadiotherapySrinivasan Vijayakumar, Johnny Yang, Mary R Nittala, et al.
Plos One|January 26, 2018
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivoMelissa Gallery, Julie Zhang, Daniel P Bradley, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cureus|November 12, 2024
Precision Population Cancer Medicine in Brain Tumors: A Potential Roadmap to Improve Outcomes and Strategize the Steps to Bring Interdisciplinary InterventionsUmesh Velu, Anshul Singh, Roselin Nittala, et al.
Cureus|March 24, 2026
High-Value Care Inclusion in the Preclinical and Clinical Years of Medical School: A Narrative Review and Descriptive Experience at a Single InstitutionLauren K Storm, John D Salvemini, Micaela L Shields, et al.
Molecular Cancer Therapeutics|December 23, 2011
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimensYuichi Hikichi, Kohei Honda, Kouki Hikami, et al.
Cureus|January 25, 2023
Changing Role of PET/CT in Cancer Care With a Focus on RadiotherapySrinivasan Vijayakumar, Johnny Yang, Mary R Nittala, et al.
Plos One|January 26, 2018
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivoMelissa Gallery, Julie Zhang, Daniel P Bradley, et al.
Pageof 3